Sign In
Buy NKTR
$72.76
+2.17 (+3.07%)
At Close: Aug 04, 2026
Nektar Therapeutics (NKTR) Reports Q1 Loss, Lags Revenue Estimates
06:47pm, Thursday, 06'th May 2021
Nektar (NKTR) delivered earnings and revenue surprises of 5.56% and -18.18%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Nektar Therapeutics Reports First Quarter 2021 Financial Results
04:15pm, Thursday, 06'th May 2021
SAN FRANCISCO, May 6, 2021 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2021. Cash and investments in marketable securiti
SAN FRANCISCO, April 27, 2021 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the first quarter 2021 on Thursday, May 6, 2021, after the close of U.S.-ba
Nektar (NKTR) Down 10.9% Since Last Earnings Report: Can It Rebound?
12:41pm, Saturday, 27'th Mar 2021
Nektar (NKTR) reported earnings 30 days ago. What's next for the stock?
Nektar Therapeutics Grinding Its Way Toward Pivotal Data
02:34pm, Monday, 08'th Mar 2021
Nektar has two major read-outs coming over the next year, including the early-stage PROPEL study in lung cancer and the PIVOT-IO-001 study in melanoma.
Nektar Therapeutics Stock Likely To See Higher Levels
08:30am, Monday, 01'st Mar 2021
Last month we talked about how Nektar Therapeutics stock seems to be a good buying opportunity, and now there have been more positive developments for the company. Last week, Nektar announced that it
Nektar Therapeutics (NKTR) CEO Howard Robin on Q4 2020 Results - Earnings Call Transcript
03:01am, Friday, 26'th Feb 2021
Nektar Therapeutics (NKTR) CEO Howard Robin on Q4 2020 Results - Earnings Call Transcript
Is a Surprise Coming for Nektar (NKTR) This Earnings Season?
09:54am, Wednesday, 24'th Feb 2021
Nektar (NKTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
SAN FRANCISCO, Feb. 18, 2021 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2020, on Thursday, February 25, 2
Will Nektar Therapeutics (NKTR) Report Negative Q4 Earnings? What You Should Know
01:42pm, Thursday, 18'th Feb 2021
Nektar (NKTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nektar Therapeutics Secures $150M From SFJ Pharma For New Study With BEMPEG/Pembrolizumab Combo In Head & Neck Cancer
09:25am, Wednesday, 17'th Feb 2021
Nektar Therapeutics (NASDAQ: NKTR) announces a financing and co-development collaboration with privately-held SFJ Pharmaceuticals to develop Bempegaldesleukin (BEMPEG) CD122-preferential IL-2–pa
Even A Novice Can Spot Nektar Therapeutics' Potential
09:45am, Tuesday, 16'th Feb 2021
NKTR's stock drop over the last few years has been exacerbated by short sellers and bad luck.
Top Stocks To Short Today As Markets Recoup Last Week's Losses
12:56pm, Tuesday, 02'nd Feb 2021
Nearly all of last week's losses have been recovered, and investors seem to be back to focusing on earnings from tech giants, stimulus progress, and the vaccine. With all of this news, Q.ai's deep lea
NKTR Stock Price Increases Over 11% Pre-Market: Why It Happened
08:25am, Monday, 01'st Feb 2021
The stock price of Nektar Therapeutics (NASDAQ: NKTR) has increased by over 11% pre-market today. This is why it happened.
Gamestopping Biopharma: These Three Stocks May See A Short Squeeze Soon
06:47am, Sunday, 31'st Jan 2021
The GameStop effect will soon come to biopharma, an usually heavily-shorted sector. Here's a list of three of biopharma's more heavily-shorted stocks.
